Trastuzumab and Pertuzumab Without Chemotherapy in Early-Stage Her2+Breast Cancer: a Plain Language Summary of the Phergain Study
AuthID
P-00X-FFH
P-00X-FFH
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service